These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8912082)

  • 1. Molecular biology of human ovarian cancer.
    Chow SN; Chien CH; Chen CT
    Int Surg; 1996; 81(2):152-7. PubMed ID: 8912082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic alterations in the genesis and development of ovarian cancer].
    Okamoto A; Yokoyama S; Terashima Y
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in the ovary.
    Berchuck A
    J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and biologic factors in the pathogenesis of ovarian cancer.
    Berek JS; Martínez-Maza O
    J Reprod Med; 1994 Apr; 39(4):241-8. PubMed ID: 8040839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma.
    Kim JW; Kim HS; Kim IK; Kim MR; Cho EY; Kim HK; Lee JM; Namkoong SE
    Gynecol Oncol; 1998 Jun; 69(3):230-6. PubMed ID: 9648593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes in ovarian cancer.
    Berchuck A; Kohler MF; Bast RC
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):813-27. PubMed ID: 1500387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay.
    Chien CH; Huang CC; Lin YH; Shen J; Chow SN
    Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.
    Rodriguez GC; Haisley C; Hurteau J; Moser TL; Whitaker R; Bast RC; Stack MS
    Gynecol Oncol; 2001 Feb; 80(2):245-53. PubMed ID: 11161867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular biology of ovarian cancer].
    Tanaka K
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2162-7. PubMed ID: 10635299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
    Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
    Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells.
    Oh HS; Moharita A; Potian JG; Whitehead IP; Livingston JC; Castro TA; Patel PS; Rameshwar P
    Cancer Res; 2004 Sep; 64(17):6327-36. PubMed ID: 15342422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.